Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease

Brain

Volumn 138, Issue 4, 2015, Pages 1046-1058

  Lai, Aaron Y ^a   Dorr, Adrienne ^a   Thomason, Lynsie A M ^a   Koletar, Margaret M ^a   Sled, John G ^b,c   Stefanovic, Bojana ^a,b   McLaurin, Jo Anne ^a  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

amyloid peptide; arterioles; cerebral amyloid angiopathy; mural cells; venules

Indexed keywords

AMYLOID BETA PROTEIN; ORANTINIB;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; BRAIN BLOOD FLOW; FUNCTIONAL DISEASE; HYPERCAPNIA; MICROVASCULATURE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; POPULATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VASCULAR DISEASE; VASOCONSTRICTION; VENULAR DEGENERATION; VENULE; 129 MOUSE; ANIMAL; BRAIN CIRCULATION; DISEASE MODEL; HAMSTER; HUMAN; MULTIPHOTON MICROSCOPY; PATHOLOGY; PROCEDURES; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; CEREBROVASCULAR CIRCULATION; CRICETINAE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, 129 STRAIN; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; VENULES;

EID: 84928821923     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv023     Document Type: Article

References (53)

1. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothe-lial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003; 112: 1142-51.
2. Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intra-cerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. J Neurol 2008; 255: 70-6.
3. Balabanov R, Beaumont T, Dore-Duffy P. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res 1999; 55: 578-87.
4. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-64.
5. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vascu-lature with kinase inhibitors. J Clin Invest 2003; 111: 1287-95.
6. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 2009; 40: S48-52.
7. Bullitt E, Gerig G, Pizer SM, Lin W, Aylward SR. Measuring tortuosity of the intracerebral vasculature from MRA images. IEEE Trans Med Imaging 2003; 22: 1163-71.
8. Carare RO, Hawkes CA, Weller RO. Afferent and efferent immuno-logical pathways of the brain. Anatomy, function and failure. Brain Behav Immun 2014; 36: 9-14.
9. Chinta LV, Lindvere L, Stefanovic B. Robust quantification of micro-vascular transit times via linear dynamical systems using two-photon fluorescence microscopy data. J Cereb Blood Flow Metab 2012; 32: 1718-24.
10. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001; 276: 21562-70.
11. Dorr A, Sahota B, Chinta LV, Brown ME, Lai AY, Ma K, et al. Amyloid-b-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 2012; 135: 3039-50.
12. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981; 7: 519-79.
13. Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990; 79: 672-9.
14. Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry 2013; 3: e233.
15. Glodzik L, Rusinek H, Brys M, Tsui WH, Switalski R, Mosconi L, et al. Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab 2011; 15: 671-9.
16. Glodzik L, Randall C, Rusinek H, de Leon MJ. Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. J Alzheimers Dis 2013; 35: 427-40.
17. Hamilton NB, Attwell D, Hall CN. Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. J Biol Chem 2001; 276: 21562-70.
18. Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 2009; 106: 1261-6.
19. Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001; 153: 543-53.
20. Hughes S, Chan-Ling T. Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci 2004; 45: 2795-806.
21. Iglewicz B, Hoaglin DC. How to detect and handle outliers. In: ASQC Basic references in quality control. Vol. vol 16. Wisconsin: ASQC Quality Press; 1993. p. 87.
22. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid b. Sci Transl Med 2012; 4: 147ra111.
23. Kalaria RN, Hedera P. Differential degeneration of the cerebral micro-vasculature in Alzheimer's disease. Neuroreport 1995; 6: 477-80.
24. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2006; 97: 2806-13.
25. Kasischke KA, Lambert EM, Panepento B, Sun A, Gelbard HA, Burgess RW, et al. Two-photon NAlzheimer's diseaseH imaging exposes boundaries of oxygen diffusion in cortical vascular supply regions. J Cereb Blood Flow Metab 2011; 31: 68-81.
26. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993; 623: 142-6.
27. Kershaw LE, Cheng HL. A general dual-bolus approach for quantitative DCE-MRI. Magn Reson Imaging 2011; 29: 160-6.
28. Kim J, Leira EC, Callison RC, Ludwig B, Moritani T, Magnotta VA, et al. Toward fully automated processing of dynamic susceptibility contrast perfusion MRI for acute ischemic cerebral stroke. Comput Methods Programs Biomed 2010; 98: 204-13.
29. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242-5.
30. Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis 2011; 23: 375-89.
31. Michaud JP, Bellavance MA, Préfontaine P, Rivest S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep 2013; 5: 646-53.
32. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann N Y Acad Sci 1997; 826: 103-16.
33. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002; 160: 985-1000.
34. Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 2011; 286: 17536-42.
35. Oishi M, Mochizuki Y, Takasu T. Regional differences in cerebrovas-cular reactivity to acetazolamide in Alzheimer's disease. J Clin Neurosci 1999; 6: 380-81.
36. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001; 222: 218-27.
37. Pieper C, Pieloch P, Galla HJ. Pericytes support neutrophil transmigration via interleukin-8 across a porcine co-culture model of the blood-brain barrier. Brain Res 2013; 1524: 1-11.
38. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. Statistics and Computing Series. New York: Springer-Verlag; 2000. p. 528.
39. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362: 329-44.
40. Růžek D, Salát J, Singh SK, Kopecký J. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8 + T-cells. PLoS One 2011; 6: e20472.
41. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 2013; 4: 2932.
42. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol 2013; 23: 303-10.
43. Scharrer E. Arteries and veins in the mammalian brain. Anat Rec 1940; 78: 173-96.
44. Shih AY, Blinder P, Tsai PS, Friedman B, Stanley G, Lyden PD, et al. The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci 2013; 16: 55-63.
45. Stefanovic B, Hutchinson E, Yakovleva V, Schram V, Russell JT, Belluscio L, et al. Functional reactivity of cerebral capillaries. J Cereb Blood Flow Metab 2008; 28: 961-72.
46. Verbeek MM, Van Nostrand WE, Otte-Höller I, Wesseling P, De Waal RM. Amyloid-beta-induced degeneration of human brain peri-cytes is dependent on the apolipoprotein E genotype. Ann N Y Acad Sci 2000; 903: 187-99.
47. Vicenzini E, Ricciardi MC, Altieri M, Puccinelli F, Bonaffini N, Di Piero V, et al. Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study. Eur Neurol 2007; 58: 84-9.
48. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 2009a; 118: 87-102.
49. Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009b; 117: 1-14.
50. Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astro-cytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 2009; 159: 1055-69.
51. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Neurosci 2011; 14: 1398-405.
52. Yang W, Wu Q, Yuan C, Gao J, Xiao M, Gu M, et al. Aquaporin-4 mediates astrocyte response to b-amyloid. Mol Cell Neurosci 2012; 49: 406-14.
53. Yezhuvath US, Uh J, Cheng Y, Martin-Cook K, Weiner M, Diaz-Arrastia R, et al. Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease. Neurobiol Aging 2012; 33: 75-82.